Background Cutaneous lupus erythematosus (CLE) is a heterogeneous autoimmune
disease with clinical sequelae such as itching, dyspigmentation and scarring. Objectives We …

Major gaps remain regarding pathogenetic mechanisms underlying clinical heterogeneity in
lupus erythematosus (LE). As systemic changes are likely to underlie skin specific …

Cutaneous features manifest as a wide range of clinically significant, and in many cases
disfiguring and debilitating components of lupus erythematosus (LE). While the definitive …

Lupus erythematosus is a heterogeneous autoimmune condition affecting multiple organs
including skin, which remains poorly understood. To investigate pathogenetic processes …

Cutaneous lupus erythematosus (CLE) is an autoimmune, connective tissue disease that
can exist as its own disease entity or within the context of systemic lupus erythematosus …

Cutaneous lupus erythematosus (CLE) is a common manifestation of systemic lupus
erythematosus (SLE), and CLE can also develop without systemic involvement. CLE can be …

Background Lupus erythematosus is an autoimmune disease that causes damage to
multiple organs ranging from skin lesions to systemic manifestations. Cutaneous lupus …

Cutaneous lupus erythematosus (CLE) is a chronic autoimmune disease of the skin with
typical clinical manifestations. Here, we genotyped 906 600 single nucleotide …

Cutaneous lupus erythematosus (CLE) is a potentially disfiguring condition frequently
associated with systemic lupus erythematosus (SLE). CLE lesions are characteristically …

Cutaneous lupus erythematosus (CLE) is a chronic inflammatory skin disease characterized
by a diverse cadre of clinical presentations. CLE commonly occurs in patients with systemic …